Study in Science holds promise for a new approach to drug therapy ( Researchers believe they have found a w...)

Study in Science holds promise for a new approach to drug therapy

Researchers believe they have found a way to change the action of 60 percent of currently available medications, in some cases making them many times more effective, according to an article published in the April 21 edition of the journal Science. The discovery has the potential to improve treatments for diseases including heart disease, cancer, diabetes, depression and arthritis. The study describes a new way to manipulate perhaps the most important signaling mechanism in human cells: G-protein coupled receptors (GPCRs).

Human cells must be able to send signals that switch life processes on and off as they react to the nutrients, toxins, hormones and even the light particles they are exposed to. GPCRs are a key part of such signaling cascades, passing on messages that make vision possible, carry nerve messages, enable white blood cells to attack infection and set the timing of the heartbeat. Faulty GPCR signaling, on the other hand, plays a key role in several major diseases. As a result, GCPRs are targeted by 12 of the top 20 selling drugs, including Coreg for congestive heart failure, Cozaar for high blood pressure, Zoladex for breast cancer, Buspar for anxiety and Clozaril for schizophrenia, as well as by Zantac and Claritin. Together the drug class accounts for $200 billion in annual sales.

Authors of the current study believe they have found a new way to regulate the same GCPR pathways, but at different points. Where most drugs change the behavior of GPCRs on the outside of cells, the new class of drugs seeks to influence related signaling on the inside. Early studies suggest that the newly discovered "drug candidates" can provide better control of pathways involved in pain relief, inflammation and heart disease, while leaving healthy functions in place.

"We believe we have discovered a new class of drugs that could make current drugs more effective, but that also represents a completely new, independent way of treating the same disease
'"/>

Source:University of Rochester Medical Center

Page: 1 2 3 4 5
Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:

(Date:6/18/2013)... , June 19, 2013 Paris Air ... as Geotest-Marvin Test Systems) , a leading provider ... aerospace industries, is demonstrating its solutions this week ... booth 3-C82. With growing challenges including increasingly complex ... demanding efficient, feature-rich, specialized aerospace test solutions that ...

(Date:6/18/2013)... of Medicine have discovered a mechanism that is used ... component of blood typically associated with clotting, were discovered ... seal it off from the rest of the body. ... this week, provide the science community with a ... known that platelets do participate in immunity, but now ...

(Date:6/18/2013)... Department,s National Renewable Energy Laboratory (NREL), and the ... describing a novel cellulose-degrading enzyme from a marine ... as the gribble. , Gribbles are biologically ... to produce their own enzymes instead of using ... eat. New biomass-degrading enzymes from novel sources such ...

Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2 Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3 Immunity mechanism discovered 2 Novel enzyme from tiny gribble could prove a boon for biofuels research 2

[0] Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show [0] Immunity mechanism discovered [0] Novel enzyme from tiny gribble could prove a boon for biofuels research

... Many would assume that "mounting an immune response" or ... thing. Now, research at the University of California, ... inflammation associated with the progression of tumors actually plays ... , The research, appearing online March 19 in advance ...

... eco-friendly, clean-burning fuel. But if every vehicle in the ... instead of pure gasoline, the number of respiratory-related deaths ... study by Stanford University atmospheric scientist Mark Z. Jacobson. ... edition of the journal Environmental Science & Technology (ES&T). ...

... the world's most endangered cat, the Amur or Far Eastern ... to 34 are left in the wild, renewing fears for ... World Wildlife Fund along with the Wildlife Conservation Society and ... Science, conducted a routine snow-track census of leopard numbers. ...

Cached Biology News:Inflammation may play role in metastasis of prostate cancer 2 Inflammation may play role in metastasis of prostate cancer 3 Ethanol vehicles pose a significant risk to human health, study finds 2 Ethanol vehicles pose a significant risk to human health, study finds 3 Amur leopard still on the brink of extinction, scientists say 2

Inflammation may play role in metastasis of prostate cancer Ethanol vehicles pose a significant risk to human health, study finds Amur leopard still on the brink of extinction, scientists say

(Date:6/18/2013)... , June 18, 2013 Techne Corporation (NASDAQ: ... it has agreed to acquire 100% ownership of ... Inc. (Bionostics). Bionostics is a global leader in ... that verify the proper operation of in ... point of care blood glucose and blood gas ...

(Date:6/18/2013)... 2013 As a leading provider ... announces the release of their infographic - " ... , MeMD's goal was to leverage an information ... 2.0, Health 3.0 and mHealth.The infographic features a ... care and the fitness industry in unimaginable ways; ...

(Date:6/18/2013)... (PRWEB) June 18, 2013 ... automated system for rapid bacterial strain typing, announced ... joined the company as Vice President of Engineering. ... for the company’s RESOLUTION™ Microbial Genotyping System ... the benchtop instrument, pathogen-specific assay kits, database and ...

(Date:6/18/2013)... June 18, 2013 Kitware , ... announces a new Fast-Track award from the U.S. Department ... environment (IDAE) for the nuclear power industry. , Construction ... more than 30 years, but the United States’ nuclear ... gains in power plant utilization through improved refueling, maintenance, ...

Breaking Biology Technology:Techne Corporation Announces Acquisition Agreement 2 Techne Corporation Announces Acquisition Agreement 3 Techne Corporation Announces Acquisition Agreement 4 Techne Corporation Announces Acquisition Agreement 5 MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2 PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2 PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3 Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2

[0] Techne Corporation Announces Acquisition Agreement [0] MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today [0] PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System [0] Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research

... International Associates Inc.,administrator for the HealthShares(TM) Indexes, a ... Funds, today announced the,quarterly rebalancing of the Indexes. ... the Indexes effective before the opening of trading ... Index (HHA) Drop GW Pharmaceuticals, Inc ...

... Mass., March 20 Interleukin,Genetics, Inc. (Amex: ILI ... and webcast on Thursday, March 27, 2008 at 4:30 ... end 2007 financial results and provide an,update on recent ... 877-440-5803 (domestic) or 719-325-4900,(international). The live webcast will be ...

... (Nasdaq:,BIOD) today announced that Gerard Michel, Chief Financial Officer, ... present a,corporate update at the BioCentury Future Leaders Conference ... The conference will be held at,the Millennium Broadway Hotel ... parties may access a link to a live webcast ...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008

Contains L-glutamine...

... does not share significant homology with ... is expressed in the central nervous ... stomach. One important role PEBP ... activity against several serine proteases including ...

...

Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....

Biology Products:

GIBCO BGJb Medium (Fitton-Jackson Modification) (1X) liquid from Invitrogen Anti-PEBP Polyclonal Antibody, unconjugated, Clone ZLK.17 from Invitrogen TriContinentMultiWash III from Femto Scientific MitoCapture Apoptosis Detection Kit from BioVision